The FDA has approved Medtronic’s hybrid closed-loop insulin delivery system for people with Type 1 diabetes, bringing the company one step closer to a fully automated, closed-loop system, or a true “artificial pancreas.” Medtronic plans to launch the hybrid closed-loop system next year … more

Separately, the company announced that Sugar.IQ with Watson, the first-of-its-kind cognitive app that helps detect important patterns and trends for people with diabetes, is now in live use for the first time … more